Effects of CC14 and DAB on Liver Damage
Author Information
Author(s): P. M. Sutton
Primary Institution: University College Hospital Medical School
Hypothesis
How do repeated doses of CC14 affect liver carcinogenesis induced by DAB?
Conclusion
The combination of CC14 and DAB led to increased bile duct activity but did not significantly change the final incidence of liver tumors compared to DAB alone.
Supporting Evidence
- Rats receiving both DAB and CC14 developed cholangiofibrosis, while those on DAB alone did not.
- Malignant tumors arose in both groups, but the incidence was similar.
- Cholangiofibrosis did not appear to be a necessary precursor of liver cancer.
Takeaway
Rats given two harmful substances together showed more signs of liver damage, but it didn't mean they got more cancer than those given just one.
Methodology
103 adult Wistar albino rats were divided into three groups and treated with DAB and CC14, with regular monitoring and histological examinations.
Limitations
The study did not explore the long-term effects beyond 36 weeks or the impact of other potential confounding factors.
Participant Demographics
Adult Wistar albino rats of both sexes, average weight 150 g.
Want to read the original?
Access the complete publication on the publisher's website